Os Therapies
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors. OST-HER2 is completing a PhIIb clinical trial in 4Q2024 with significantly improved Event Free Survival (EFS), and early Overall Survival (OS). OST-tADC is a ph-sensitive novel pre-clinical Drug Conjugate that uses proprietary (IP) Silicon to cover and link the multiple payloads until they are delivered to the acidic cancer environment, dissolving the Silicon - delivering and activating the payloads.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Os Therapies
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- PR
Paul Romness
CEO · Other
EmailPhone - CA
Christopher Acevedo
Chief Financial Officer · Finance & Accounting
EmailPhone - JD
John Doll
Chief of Staff · Operations
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Os Therapies
3 distinct titles indexed · top 3 shown.
- 1ceo
- 1chief financial officer
- 1chief of staff
Sign up to unlock all 4 contacts at Os Therapies
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Os Therapies
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.